Eva Andres-Mateos

Associate Vice President - Preclinical Development - Gene Therapy @Eli Lilly and Company

Boston, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Oct 2024 — Present

Associate Vice President - Preclinical Development - Gene Therapy @Eli Lilly and Company

View department →

Boston, MA, US

EDUCATION

N/A

Universidad Complutense de Madrid

Master of Pharmacy (MPharm)

N/A

Universidad Autónoma de Madrid

Doctor of Philosophy (Ph.D.)

ABOUT EVA ANDRES-MATEOS

Results-oriented leader with broad scientific and technical background in gene therapy and bioanalytical development. Expertise in pharmacology, toxicology, and molecular and cell biology.Demonstrated success in building strong teams and cross-functional processes, and leading the effective execution of regulatory strategies from preclinical discovery to early clinical stage.Strong organizational, interpersonal and communication skills.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Eva Andres-Mateos — Associate Vice President - Preclinical Development - Gene Therapy at Eli Lilly and Company in Boston, MA, US | Unifers